Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8256935003
Price
4.53 USD
Market cap
21.58 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
Shuttle Pharmaceuticals Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -11.92 m USD |
| EBIT | -11.72 m USD |
| Net income | -11.72 m USD |
| Diluted EPS – continuing operations | -7.16 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
More stocks
- All In FutureTech Alliance, Inc. (AIFA)
- SURGE COMPONENTS INC (SPRS)
- Nexscient, Inc. (NXNT)
- RETRACTABLE TECHNOLOGIES INC (RVP)
- CLEARONE INC (CLRO)
- SolarMax Technology, Inc. (SMXT)
- TANDY LEATHER FACTORY INC (TLF)
- VEEA INC. (VEEA)
- MEXCO ENERGY CORP (MXC)
- ATOSSA THERAPEUTICS, INC. (ATOS)
- PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
- MASS MEGAWATTS WIND POWER INC (MMMW)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.